Table 1.

Characteristics of outpatient kidney transplant recipients with known coronavirus disease 2019 versus suspected coronavirus disease 2019

Characteristicn (%) or Median (IQR)
AllSuspected COVID-19 (PUI)Known COVID-19
n4119 (46)22 (54)
Men30 (73)13 (68)17 (77)
Age, yr49 (41–63)49 (38–62)52 (42–64)
Time since transplant, mo42 (18–66)39 (18–61)43 (17–98)
Deceased donor kidney recipient23 (56)12 (63)11 (50)
Hypertension37 (90)17 (89)20 (91)
Diabetes mellitus11 (27)5 (26)6 (27)
Body mass index, kg/m226.6 (25.7–32.0)27.5 (24.8–32.5)26.5 (25.8–27.9)
Obese, body mass index ≥30 kg/m212 (29)7 (37)5 (22)
Angiotensin-converting enzyme inhibitor use3 (7)2 (11)1 (5)
Angiotensin receptor blocker use6 (15)1 (5)5 (22)
Maintenance immunosuppression
 Calcineurin inhibitor31 (76)16 (84)15 (68)
 Mycophenolate mofetil/mycophenolate sodium31 (76)14 (74)17 (77)
 Belatacept9 (22)3 (16)6 (27)
 Prednisone16 (39)7 (37)9 (41)
 Azathioprine5 (12)4 (21)1 (5)
Known sick contact21 (51)13 (68)8 (36)
Symptoms
 Fever33 (80)11 (58)22 (100)
 Cough23 (56)14 (74)9 (41)
 Dyspnea (exertional or rest)16 (39)6 (32)10 (45)
 Gastrointestinal11 (27)6 (32)5 (23)
 Myalgia/arthralgia11 (27)7 (37)4 (18)
 Fatigue/malaise10 (24)8 (36)2 (11)
 Headache3 (7)1 (5)2 (9)
 Chills2 (5)0 (0)2 (9)
Symptoms improved as outpatient23 (56)15 (79)8 (36)
Admitted to hospital13 (32)1 (5)12 (55)
  • IQR, interquartile range; COVID-19, coronavirus disease 2019; PUI, person under investigation.